{"id":"W2794690006","doi":"10.1002/pbc.27023","title":"Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial","year":2018,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation; Children's Neuroblastoma Cancer Foundation","keywords":"Medicine; Neuroblastoma; Vorinostat; Isotretinoin; Refractory (planetary science); Oncology; Clinical trial; Internal medicine; Cancer research; Dermatology; Genetics; Histone; Histone deacetylase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001376747,0.0003687645,0.0005964752,0.0008060135,0.00005089445,0.00002454454,0.0001806686,0.00006179654,0.00004487197],"category_scores_gemma":[0.00005530196,0.0002628122,0.00004876713,0.001735423,0.0000626133,0.0001699586,0.00006724154,0.0003595988,0.00000796828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000931619,"about_ca_system_score_gemma":0.0005219511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006729695,"about_ca_topic_score_gemma":0.001726407,"domain_scores_codex":[0.9970201,0.0002048455,0.0005351146,0.0007318219,0.0009421702,0.00056593],"domain_scores_gemma":[0.9986991,0.00009970126,0.0002519668,0.0004335,0.0001608685,0.0003549231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2550963,0.06862531,0.6521388,0.00008597769,0.0001323207,0.0001810269,0.002052448,0.00001826526,0.00003825743,0.000002726588,0.0001817062,0.02144684],"study_design_scores_gemma":[0.3509274,0.1911972,0.4567007,0.00007558672,0.0001771476,0.000003881972,0.00005729867,0.00003063752,0.0005604271,0.000003151908,0.00006237107,0.0002041334],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944432,0.0001020896,0.000005610829,0.0001985586,0.0001654961,0.00497827,0.0000252894,0.0000374182,0.00004407063],"genre_scores_gemma":[0.9988971,0.0000892752,0.00009529857,0.00006121185,0.0003249408,0.0003913052,0.00001486541,0.0000648552,0.00006110096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1954381,"threshold_uncertainty_score":0.9999824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0533307255140484,"score_gpt":0.3062926105779968,"score_spread":0.2529618850639484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}